BioRegion Real Estate

Premium

Sanofi-aventis Kicks Off €200M Conversion of French Pharma Plant into Biotech Facility

Sanofi-aventis said this week it will spend €200M ($266 million) to transform its pharmaceuticals production site in Vitry-sur-Seine, France, into a facility for researching, developing, then producing biotechnology products through alliances with smaller biotech companies. Starting in 2012, for example, the plant is expected to create the company’s first cell culture biotechnoloy platform designed to produce monoclonal antibodies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.